Indonesia has stopped providing researchers with genetic samples collected from new cases of bird flu, saying that it wants to protect its intellectual property rights in the development of a new vaccine. Sometime tomorrow Baxter International is expected to announce a deal with the government to develop a new vaccine for bird flu. Health officials say the move is likely to slow development of a defense against a potential pandemic. Analysts expect that the Indonesian government is looking to cut a deal that delivers the IP in exchange for a cut-rate price on a new vaccine.
- read the report on the Indonesian deal from the Financial Times
Related Articles:
Indonesia identifies new clusters of avian flu cases. Report
Baxter partners with biotech on blood clotting. Report
FDA grants tentative approval to Baxter. Report